Pharmaceutical Market Access, Pricing and Reimbursement 2016 Europe is a conference dedicated to top tier government, hospitals, pharmaceuticals, bio-pharmaceuticals and non-profit organizations.
Topics
- Early Market Access of Health Technologies: The implications.
- Market Access strategies: How can we maximize our strategies?
- Emerging Markets: What knowledge, strategies and resources will be needed to maximize pricing and access and hurdles faced.
- Challenges & Opportunities in pharma pricing, reimbursement and market access: Changing market trends and influences
- Patient Access: How can this continue to improve?
- Pricing & Reimbursement: for Orphan Drugs and Biosimilars
- International Collaboration: Where do we agree and differ?
- Data Collection & Management: Using Real World Evidence and Patient Reported Outcomes for pricing and access
- Looking to the Future: What lies ahead?
Who should Attend
Attendees involved or interested in:
- Pricing and Reimbursement
- Market Access
- Health Economics and Outcomes Research
- Patient Outcomes
- Data Management/ Analysis
- Payer Relations/ Evidence
- Public/ Government Affairs
- Regulatory Affairs
- Payer, HTA Officials and Physicians
